Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$1.94 - $2.55 $52,624 - $69,171
-27,126 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$1.69 - $2.67 $147,503 - $233,037
-87,280 Reduced 76.29%
27,126 $65,000
Q1 2021

May 17, 2021

BUY
$1.79 - $2.91 $204,786 - $332,921
114,406 New
114,406 $229,000

Others Institutions Holding VBLT

About Vascular Biogenics Ltd.


  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.